The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics

The development of psychotic symptoms is traditionally linked to the increase of the functional activity of endogenous dopaminergic system. Antipsychotic effect of existing medications is associated with direct blockade of postsynaptic dopamine receptors. However, direct antagonistic activity is «al...

Full description

Bibliographic Details
Main Authors: V. I. Kozlovskiy, D. N. Kosterin, M. Yu. Popov
Format: Article
Language:Russian
Published: Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2019-05-01
Series:Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:
Online Access:https://www.bekhterevreview.com/jour/article/view/227
_version_ 1826573146195492864
author V. I. Kozlovskiy
D. N. Kosterin
M. Yu. Popov
author_facet V. I. Kozlovskiy
D. N. Kosterin
M. Yu. Popov
author_sort V. I. Kozlovskiy
collection DOAJ
description The development of psychotic symptoms is traditionally linked to the increase of the functional activity of endogenous dopaminergic system. Antipsychotic effect of existing medications is associated with direct blockade of postsynaptic dopamine receptors. However, direct antagonistic activity is «alien» to physiological mechanisms of neurotransmission modulation, and presynaptic autoreceptor blockade mау produce a reverse (agonistic) effect, enhancing neurotransmitter release. On the other hand, anti-dopamine effect can be achieved by indirect antagonistic activity—by presynaptic dopamine depletion, which is consistent with the natural, physiological mechanisms of reducing neurotransmission. It can be assumed that modulation of presynaptic regulation is one of the promising directions for the development of antipsychotic drugs of future generations.
first_indexed 2024-03-12T03:01:39Z
format Article
id doaj.art-f3747441b307495189adcc7827a6f86d
institution Directory Open Access Journal
issn 2313-7053
2713-055X
language Russian
last_indexed 2025-03-14T12:38:16Z
publishDate 2019-05-01
publisher Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
record_format Article
series Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
spelling doaj.art-f3747441b307495189adcc7827a6f86d2025-03-02T09:12:44ZrusFederal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian FederationОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева2313-70532713-055X2019-05-01013710.31363/2313-7053-2019-1-3-7224The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychoticsV. I. Kozlovskiy0D. N. Kosterin1M. Yu. Popov2V.M. Bekhterev National Medical Research Centre of Psychiatry and Neurology, St. PetersburgV.M. Bekhterev National Medical Research Centre of Psychiatry and Neurology, St. PetersburgV.M. Bekhterev National Medical Research Centre of Psychiatry and Neurology, St. PetersburgThe development of psychotic symptoms is traditionally linked to the increase of the functional activity of endogenous dopaminergic system. Antipsychotic effect of existing medications is associated with direct blockade of postsynaptic dopamine receptors. However, direct antagonistic activity is «alien» to physiological mechanisms of neurotransmission modulation, and presynaptic autoreceptor blockade mау produce a reverse (agonistic) effect, enhancing neurotransmitter release. On the other hand, anti-dopamine effect can be achieved by indirect antagonistic activity—by presynaptic dopamine depletion, which is consistent with the natural, physiological mechanisms of reducing neurotransmission. It can be assumed that modulation of presynaptic regulation is one of the promising directions for the development of antipsychotic drugs of future generations.https://www.bekhterevreview.com/jour/article/view/227antipsychoticsdirect- and indirectacting antagonistspre- and postsynaptic mechanisms of action
spellingShingle V. I. Kozlovskiy
D. N. Kosterin
M. Yu. Popov
The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
antipsychotics
direct- and indirectacting antagonists
pre- and postsynaptic mechanisms of action
title The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics
title_full The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics
title_fullStr The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics
title_full_unstemmed The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics
title_short The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics
title_sort role of agonistic antagonistic activity in the development of psychotropic effects of antipsychotics
topic antipsychotics
direct- and indirectacting antagonists
pre- and postsynaptic mechanisms of action
url https://www.bekhterevreview.com/jour/article/view/227
work_keys_str_mv AT vikozlovskiy theroleofagonisticantagonisticactivityinthedevelopmentofpsychotropiceffectsofantipsychotics
AT dnkosterin theroleofagonisticantagonisticactivityinthedevelopmentofpsychotropiceffectsofantipsychotics
AT myupopov theroleofagonisticantagonisticactivityinthedevelopmentofpsychotropiceffectsofantipsychotics
AT vikozlovskiy roleofagonisticantagonisticactivityinthedevelopmentofpsychotropiceffectsofantipsychotics
AT dnkosterin roleofagonisticantagonisticactivityinthedevelopmentofpsychotropiceffectsofantipsychotics
AT myupopov roleofagonisticantagonisticactivityinthedevelopmentofpsychotropiceffectsofantipsychotics